Pharmaniaga posts steady Q1 profit, to expand vaccine business as Covid-19 rages   

KUALA LUMPUR: Pharmaniaga Bhd said revenue from its Sinovac Covid-19 business to start coming in from the June quarter onwards.

"The distribution of the first batch of 290,480 doses of the vaccine to the market has commenced on May 11," the company said in a filing with Bursa Malaysia today.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Pharmaniaga , Sinovac , Vaccine

   

Report it to us.

Next In Business News
Wall St set to kick off week higher; U.S. inflation in focus
Opcom auditor resigns after audit fee disagreement
Ringgit closes easier against US dollar as greenback gathers strength
Maxis appoints MR DIY CEO Adrian Ong as director
Optimax secures license to offer plastic surgery and aesthetic services
TCS wins RM10.7mil construction contract
EVE Energy builds new US$422mil manufacturing facility in Kulim, kedah
UMW Toyota July sales jump 25.8% to 8,349 units
KLCI ends flat on cautious investor sentiment
Maybank2u and MAE apps currently down; credit and debit card use also unavailable (Updated: Services back to normal)

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.